Health ministry concludes national review meeting on disease surveillance and public health programmes

Mumbai: As part of the Government of India’s continued efforts to strengthen disease surveillance systems and enhance preparedness against emerging public health threats, the Union ministry of health and family welfare organised a two-day National Review Meeting on Disease Surveillance and Public Health Programmes at New Delhi.

The meeting brought together senior health leadership from all 36 States and Union Territories to review the implementation of key public health programmes, assess progress in disease surveillance, and deliberate on strategies to strengthen data-driven governance through a structured framework of key performance indicators (KPIs).

The meeting was inaugurated by Dr. Rakesh Gupta, Additional Secretary (Public Health), ministry of health and family welfare, in the presence of Dr. Loveneesh G. Krishna, director general of health services (DGHS); Sukhlal Meena, director (Public Health); and Dr. Arti Bahl, additional director, National Centre for Disease Control (NCDC) and representatives from key development partner organisations.

During the two-day meeting, state and Union Territory representatives reviewed the progress of key national public health programmes with a focus on strengthening data-driven governance through a structured framework of key performance indicators (KPIs).

Detailed deliberations were held on the National One Health Programme for Prevention and Control of Zoonoses, National Rabies Control Programme, Programme for Prevention and Control of Leptospirosis, National Programme for Prevention and Control of Snakebite Envenoming, Disaster Management, Integrated Disease Surveillance Programme (IDSP), Pandemic Preparedness, Field Epidemiology Training Programme (FETP), Antimicrobial Resistance (AMR), National Programme on Climate Change and Human Health, and the National Bio-Monitoring Programme for Chemical Toxicants.

A key outcome of the meeting was the unanimous adoption of the key performance indicator (KPI) framework by all 36 States and Union Territories, with a commitment to achieving defined targets and performance benchmarks for strengthening the implementation, monitoring and evaluation of key public health programmes.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre